Ligand id: 9094

Name: lanadelumab

Compound class Antibody
Approved drug? Yes (EMA & FDA (2018))
International Nonproprietary Names
INN number INN
10265 lanadelumab
DX-2930 | lanadelumab-flyo | Takhzyro® | X124-G01
Lanadelumab is a fully human monoclonal antibody targeting the serine peptidase kallikrein B1 (KLKB1, a.k.a. plasma kallikrein). It is generated in recombinant Chinese hamster ovary cells.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. Protein BLAST analysis reveals 100% matches with peptides claimed in patent US8816055 [1].
Database Links
Specialist databases
IMGT/mAb-DB 607
Other databases
GtoPdb PubChem SID 315661179
Search PubMed clinical trials lanadelumab
Search PubMed titles lanadelumab
Search PubMed titles/abstracts lanadelumab